dorzolamide

The medicine is recommended for the treatment of glaucoma to lower elevated intraocular pressure when the use of other eye drops does not provide sufficient effects.

Form: drops, ophthalmic solution

ATC: S01ED51

Manufacturer: Santen OY Tubilux Pharma S.P.A.

The medicine is recommended for the treatment of glaucoma to lower elevated intraocular pressure when using eye drops containing only a beta-adrenergic receptor blocker is not sufficient.

Form: drops, ophthalmic solution

ATC: S01ED51

Manufacturer: Pharma Stulln GmbH

The medicine is recommended for the treatment of glaucoma to lower elevated intraocular pressure when using eye drops containing only a beta-blocker is not sufficient.

Form: drops, ophthalmic solution in single-dose container

ATC: S01ED51

Manufacturer: Pharma Stulln GmbH

It is used to reduce increased intraocular pressure and for the treatment of glaucoma.

Form: drops, ophthalmic solution

ATC: S01EC03

Manufacturer: Rafarm S.A.

The medicine is used in the treatment of glaucoma to lower elevated intraocular pressure when using eye drops containing only a beta-adrenergic receptor blocker alone is not sufficient.

Form: drops, ophthalmic solution

ATC: S01ED51

Manufacturer: Rafarm S.A.

The medicine is recommended for the treatment of glaucoma to reduce elevated intraocular pressure when the use of single-ingredient eye drops alone is not sufficient.

Form: drops, ophthalmic solution

ATC: S01ED51

Manufacturer: Adamed Pharma S.A. Rafarm S.A.

The medicine is used to reduce elevated intraocular pressure in people suffering from ocular hypertension, open-angle glaucoma, and angle-closure glaucoma.

Form: drops, ophthalmic solution

ATC: S01EC03

Manufacturer: Adamed Pharma S.A. RAFARM S.A.

The medicine is recommended for the treatment of glaucoma to reduce elevated intraocular pressure.

Form: drops, ophthalmic solution

ATC: S01ED51

Manufacturer: Pharmathen S.A.